File:Strategy for the development of engineered live bacterial therapeutic clinical candidates.pdf

Original file(675 × 787 pixels, file size: 396 KB, MIME type: application/pdf)

Summary

Description
English: Schematic representation of a workflow for developing clinical candidate-quality engineered strains. The development workflow should incorporate technologies for optimizing strain potency, as well as predictive in vitro and in vivo assays, as well quantitative pharmacology models, to maximize translational potential for patient populations.[1]
Date
Source https://doi.org/10.1038/s41467-020-15508-1
Author Mark R. Charbonneau, Vincent M. Isabella, Ning Li & Caroline B. Kurtz

Licensing

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  1. Template:CC-notice

Captions

Strategy for the development of engineered live bacterial therapeutic clinical candidates

Items portrayed in this file

depicts

8 April 2020

application/pdf

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current17:45, 8 April 2020Thumbnail for version as of 17:45, 8 April 2020675 × 787 (396 KB)Rob HurtUploaded a work by Mark R. Charbonneau, Vincent M. Isabella, Ning Li & Caroline B. Kurtz from https://doi.org/10.1038/s41467-020-15508-1 with UploadWizard
The following pages on the English Wikipedia use this file (pages on other projects are not listed):

Global file usage

The following other wikis use this file:

Metadata